edetic acid has been researched along with razoxane in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boggust, WA; McGauley, H | 1 |
| Baldini, L; Bartoli Klugmann, F; Benussi, B; Decorti, G; Grill, V; Klugmann, S; Mallardi, F | 1 |
| Hasinoff, BB | 2 |
| Bast, A; van Acker, SA; van Asbeck, BS; van der Vijgh, WJ; Voest, EE | 1 |
| Hua, HY; Zhang, TM; Zhang, Y | 1 |
| Thomas, C; Vile, GF; Winterbourn, CC | 1 |
| Hider, RC; Tilbrook, GS | 1 |
| Anandasbapathy, S; Elihu, N; Frishman, WH | 1 |
| Clarke, JJ; Dunkel, VC; San, RH; Seifried, HE; Whittaker, P | 1 |
| Jirkovská, A; Karabanovich, G; Piskáčková, HB; Reimerová, P; Roh, J; Šimůnek, T; Štěrbová-Kovaříková, P | 1 |
3 review(s) available for edetic acid and razoxane
| Article | Year |
|---|---|
Iron chelators for clinical use.
Topics: Biological Transport; Deferoxamine; Drug Delivery Systems; Edetic Acid; Ferric Compounds; Free Radical Scavengers; Humans; Iron; Iron Chelating Agents; Iron Overload; Ligands; Molecular Weight; Oxidation-Reduction; Pentetic Acid; Razoxane; Solubility; Structure-Activity Relationship; Tissue Distribution | 1998 |
Chelation therapy in cardiovascular disease: ethylenediaminetetraacetic acid, deferoxamine, and dexrazoxane.
Topics: Antibiotics, Antineoplastic; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Deferoxamine; Doxorubicin; Edetic Acid; Female; Humans; Iron; Razoxane | 1998 |
Dexrazoxane use in the prevention of anthracycline extravasation injury.
Topics: Anthracyclines; Clinical Trials as Topic; Edetic Acid; Extravasation of Diagnostic and Therapeutic Materials; Molecular Structure; Razoxane | 2006 |
8 other study(ies) available for edetic acid and razoxane
| Article | Year |
|---|---|
Inhibition of collagen peptidase in HeLa cells and human tumours by compounds including drugs used in cancer therapy.
Topics: Antineoplastic Agents; Aprotinin; Collagen; Cyclophosphamide; Edetic Acid; Fluorouracil; HeLa Cells; Humans; Microbial Collagenase; Neoplasms; Phenanthrolines; Razoxane; Thiotepa | 1978 |
Effects of ICRF 159 on adriamycin-induced cardiomyopathy in rats.
Topics: Animals; Calcium; Cardiomyopathies; Doxorubicin; Edetic Acid; Male; Myocardium; Piperazines; Prognosis; Rats; Rats, Inbred Strains; Razoxane | 1983 |
NADPH-cytochrome-P450 reductase promotes hydroxyl radical production by the iron complex of ADR-925, the hydrolysis product of ICRF-187 (dexrazoxane).
Topics: Animals; Catalase; Chelating Agents; Edetic Acid; Electron Spin Resonance Spectroscopy; Ethylenediamines; Glycine; Hydroxyl Radical; Iron Chelating Agents; Models, Chemical; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Rats; Razoxane; Spectrophotometry, Ultraviolet | 1995 |
Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicity.
Topics: Animals; Atrial Function; Cyclic N-Oxides; Deferoxamine; Doxorubicin; Drug Evaluation, Preclinical; Edetic Acid; Heart; Heart Atria; Hydrogen Peroxide; In Vitro Techniques; Iron Chelating Agents; Male; Mice; Mice, Inbred BALB C; Myocardial Contraction; Pyridones; Razoxane | 1994 |
Inhibitory effect of dioxopiperazine compounds on malondialdehyde formation induced by doxorubicin in rat liver mitochondria in vitro.
Topics: Animals; Antineoplastic Agents; Chlorides; Doxorubicin; Edetic Acid; Ferric Compounds; In Vitro Techniques; Male; Malondialdehyde; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Razoxane | 1993 |
The hydrolysis product of ICRF-187 promotes iron-catalysed hydroxyl radical production via the Fenton reaction.
Topics: Ascorbic Acid; Chelating Agents; Deoxyribose; Dimethyl Sulfoxide; Doxorubicin; Edetic Acid; Ethylenediamines; Ferric Compounds; Glycine; Hydrogen Peroxide; Hydrolysis; Hydroxides; Hydroxyl Radical; Iron; Kinetics; Oxidation-Reduction; Paraquat; Razoxane; Superoxides; Thiobarbituric Acid Reactive Substances; Xanthine Oxidase | 1993 |
Genotoxicity of iron chelators in L5178Y mouse lymphoma cells.
Topics: Animals; Deferiprone; Edetic Acid; Iron Chelating Agents; Lymphoma; Mice; Mutagenicity Tests; Phenanthrolines; Pyridones; Razoxane; Tumor Cells, Cultured | 2001 |
UHPLC-MS/MS method for analysis of sobuzoxane, its active form ICRF-154 and metabolite EDTA-diamide and its application to bioactivation study.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chromatography, High Pressure Liquid; Edetic Acid; Myocytes, Cardiac; Piperazines; Rats; Rats, Wistar; Razoxane; Tandem Mass Spectrometry | 2019 |